Please enable Javascript
The HemOnc Pulse
Meeting News
The HemOnc Pulse Live
Video Insights
In Print
Subscribe
Leukemia
Acute Lymphoblastic Leukemia
Acute Myeloid Leukemia
Chronic Lymphocytic Leukemia
Chronic Myeloid Leukemia
Lymphoma
Aggressive B-Cell Lymphoma
Hodgkin Lymphoma
Indolent B-Cell Lymphoma
Mantle Cell Lymphoma
T-Cell Lymphoma
MPN
Myelofibrosis
Polycythemia Vera
MDS
Myeloma
Transplantation & Cellular Therapy
Eric Winer, MD
Articles by Eric Winer, MD
How Will AML Treatment Evolve?
Eric Winer, MD
Video Insights
|
July 30, 2024
Drs. Winer, Daver, and Abaza discuss how the treatment of AML will evolve in the future.
View More
Treatment Strategies in Older Patients With AML
Eric Winer, MD
Video Insights
|
July 17, 2024
Drs. Winer, Daver, and Abaza discuss the optimal treatment for older patients with AML.
View More
What Important Breakthroughs Are Needed in AML Treatment?
Eric Winer, MD
Video Insights
|
June 26, 2024
Drs. Winer, Daver, and Abaza share their thoughts on the next major breakthroughs in the treatment of AML.
View More
The Current State of Emavusertib in AML Therapy
Eric Winer, MD
Video Insights
|
June 25, 2024
Drs. Winer, Daver, and Abaza share their thoughts and experiences with emavusertib in patients with AML.
View More
What Are The Biggest Breakthroughs in AML Treatment?
Eric Winer, MD
Video Insights
|
June 21, 2024
Drs. Winer, Daver, and Abaza discuss the major breakthroughs in the treatment of acute myeloid leukemia.
View More
Experts Outline Treatment Algorithms for AML With the Latest Data
Eric Winer, MD
Video Insights
|
June 17, 2024
Drs. Winer, Abaza, and Daver discuss their own treatment strategies for patients with AML.
View More
Eric Winer, MD, on the Potential of Emavusertib
Cecilia Brown
Video Insights
|
June 13, 2023
Dr. Winer discusses emavusertib, an orally bioavailable, reversible inhibitor of IRAK4.
View More